✦ LIBER ✦

Asian Ethnicity as a Predictor of Response in Patients with Non–Small-Cell Lung Cancer Treated with Gefitinib on an Expanded Access Program

✍ Scribed by Sheeba K. Thomas; Frank V. Fossella; Diane Liu; Rainell Schaerer; Anne S. Tsao; Merrill S. Kies; Katherine M. Pisters; George R. Blumenschein Jr.; Bonnie S. Glisson; J. Jack Lee; Roy S. Herbst; Ralph G. Zinner

Book ID: 115076623
Publisher: CIG Media Group, LP.
Year: 2006
Tongue: English
Weight: 898 KB
Volume: 7
Category: Article
ISSN: 1525-7304
DOI: 10.3816/clc.2006.n.014

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-518 Asian ethnicity as a predictor of

P-518 Asian ethnicity as a predictor of response to gefitinib in non-small cell lung cancer

✍ Koshy, S.; Fossella, F.; Liu, D.; Schaerer, R.; Tsao, A.; Kies, M.; Pisters, K.; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 153 KB

Antitumor Activity and Tolerability of G

Antitumor Activity and Tolerability of Gefitinib in Patients with Non–Small-Cell Lung Cancer Treated in an Expanded Access Program

✍ Neelam T. Shah; Vincent A. Miller 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 781 KB

Efficacy and safety of gefitinib in chem

Efficacy and safety of gefitinib in chemonaive patients with advanced non-small cell lung cancer treated in an Expanded Access Program

✍ Govindan, Ramaswamy; Natale, Ronald; Wade, James; Herbst, Roy; Krebs, Annetta; R 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Outcomes of patients with advanced non-s

Outcomes of patients with advanced non-small cell lung cancer treated with gefitinib (ZD1839, ‘Iressa’) on an expanded access study

✍ Jänne, Pasi A.; Gurubhagavatula, Sarada; Yeap, Beow Y.; Lucca, Joan; Ostler, Pat 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Serum tumor markers as predictors for su

Serum tumor markers as predictors for survival in advanced non-small cell lung cancer patients treated with gefitinib

✍ Chiu, Chao-Hua; Shih, Yu-Ning; Tsai, Chun-Ming; Liou, Jia-Ling; Chen, Yuh-Min; P 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 235 KB

825 Statistical analysis of survival in

825 Statistical analysis of survival in patients with advanced non-small-cell lung cancer (NSCLC) treated with gefitinib (‘Iressa’, ZD1839) in an expanded access program (EAP): preliminary results

✍ M. Wolf; D. Farina-Sisofo; J. Grous; G. Kennealey; J. Ochs 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 166 KB